BioHealth News

Vanda Pharmaceuticals and Anaptys Announce Exclusive Global License Agreement for Vanda to Develop and Commercialize Imsidolimab, an IL-36R Antagonist

Vanda Pharmaceuticals and Anaptys Announce Exclusive Global License Agreement for Vanda to Develop and Commercialize Imsidolimab, an IL-36R Antagonist

WASHINGTON and SAN DIEGO, Feb. 3, 2025 /PRNewswire/ -- Vanda Pharmaceuticals Inc. (Vanda) (Nasdaq: VNDA) and AnaptysBio, Inc. (Anaptys) (Nasdaq: ANAB) today announced an exclusive, global license agreement for the development…

Read More
Supernus Announces FDA Approval of ONAPGO™ (apomorphine hydrochloride) for Parkinson’s Disease

Supernus Announces FDA Approval of ONAPGO™ (apomorphine hydrochloride) for Parkinson’s Disease

ROCKVILLE, Md., Feb. 04, 2025 (GLOBE NEWSWIRE) -- Supernus Pharmaceuticals, Inc. (Nasdaq: SUPN), a biopharmaceutical company focused on developing and commercializing products for the treatment of central nervous…

Read More
United Therapeutics Corporation Announces Full Enrollment of the TETON 1 Study of Inhaled Treprostinil for the Treatment of Idiopathic Pulmonary Fibrosis

United Therapeutics Corporation Announces Full Enrollment of the TETON 1 Study of Inhaled Treprostinil for the Treatment of Idiopathic Pulmonary Fibrosis

Over 100,000 patients in the United States have IPF, with only two approved therapies available that only slow the course of disease progression Top line data…

Read More
United Therapeutics Corporation Announces FDA Clearance of its Investigational New Drug Application for the UKidney Xenotransplantation Clinical Trial

United Therapeutics Corporation Announces FDA Clearance of its Investigational New Drug Application for the UKidney Xenotransplantation Clinical Trial

SILVER SPRING, Md. & RESEARCH TRIANGLE PARK, N.C.--(BUSINESS WIRE)--United Therapeutics Corporation (Nasdaq: UTHR), a public benefit corporation, today announced that the U.S. Food and Drug…

Read More
MCEDC: Nearly $3 Billion Invested in Montgomery County, Maryland Companies in 2024

MCEDC: Nearly $3 Billion Invested in Montgomery County, Maryland Companies in 2024

MONTGOMERY COUNTY, Md. — Businesses in Maryland’s Montgomery County experienced a surge in investment funding in 2024. Mergers and acquisitions, venture capital and private…

Read More
Georgetown Entrepreneurs Win $150,000 in Prizes During Annual ‘Bark Tank’ Pitch Competition

Georgetown Entrepreneurs Win $150,000 in Prizes During Annual ‘Bark Tank’ Pitch Competition

Eight student teams on a mission to make a positive impact on society presented their startup ideas to a panel of expert judges during…

Read More
Theradaptive’s OsteoAdapt™ SP Launches in Maryland with First Patient Dosed and $1 Million MSCRF Grant Support

Theradaptive’s OsteoAdapt™ SP Launches in Maryland with First Patient Dosed and $1 Million MSCRF Grant Support

FREDERICK, Md., Jan. 30, 2025 /PRNewswire-PRWeb/ -- Theradaptive, a Maryland-based, privately held, clinical-stage biologics company, today announced the initiation of patient dosing in Maryland for the ongoing OASIS Phase I/II clinical…

Read More
MaxCyte® Acquires SeQure Dx to Broaden Cell Engineering Offerings with On-target and Off-target Editing Assessments

MaxCyte® Acquires SeQure Dx to Broaden Cell Engineering Offerings with On-target and Off-target Editing Assessments

ROCKVILLE, Md., Jan. 30, 2025 (GLOBE NEWSWIRE) -- MaxCyte, Inc., (Nasdaq: MXCT; LSE: MXCT), a leading, cell-engineering focused company providing solutions to advance the…

Read More
citybiz: ETC Baltimore Marks Milestone with Opening of Venture Hub at Connect Labs Baltimore

citybiz: ETC Baltimore Marks Milestone with Opening of Venture Hub at Connect Labs Baltimore

ETC Baltimore, dedicated to elevating Baltimore as a national leader in tech startups, announces the opening of its inaugural ETC Venture Hub at Connect Labs Baltimore in the newly…

Read More
Exciting Opportunities for BioHealth Companies in Montgomery County, MD in 2025 and Beyond

Exciting Opportunities for BioHealth Companies in Montgomery County, MD in 2025 and Beyond

For the second year in a row, the BioHealth Capital Region (BHCR) has been ranked as a Top 3 BioCluster Hub by Genetic Engineering…

Read More
Kalocyte Selected to Join Blue Knight

Kalocyte Selected to Join Blue Knight

BALTIMORE, January 28, 2025 – KaloCyte, Inc., a pre-clinical biotech startup company developing a bio-inspired red blood cell substitute called ErythroMer™, announced today that it has…

Read More
MIMETAS Launches OrganoPlate UniFlow Technology at SLAS 2025

MIMETAS Launches OrganoPlate UniFlow Technology at SLAS 2025

LEIDEN, Netherlands, January 28, 2025 / Biotech Newswire / -- MIMETAS, a global leader in human disease modeling, has launched OrganoPlate UniFlow (UF), the first…

Read More
Processa Pharmaceuticals Announces Pricing of $5 Million Public Offering Priced At-The-Market Under Nasdaq Rules

Processa Pharmaceuticals Announces Pricing of $5 Million Public Offering Priced At-The-Market Under Nasdaq Rules

HANOVER, MD, Jan. 27, 2025 (GLOBE NEWSWIRE) -- Processa Pharmaceuticals, Inc. (Nasdaq: PCSA) (“Processa” or the “Company”), a clinical-stage pharmaceutical company focused on developing…

Read More
TEDCO Invests in ReBokeh

TEDCO Invests in ReBokeh

COLUMBIA, Md., (January 27, 2025) — TEDCO, Maryland’s economic engine for technology companies, announced a recent $100,000 investment in ReBokeh through the Pre-Seed Builder…

Read More
MedStar Health First in Maryland to Implant FDA Approved Tricuspid Valves in Patients Without Need for Open Heart Surgery

MedStar Health First in Maryland to Implant FDA Approved Tricuspid Valves in Patients Without Need for Open Heart Surgery

BALTIMORE, Jan. 24, 2025 /PRNewswire/ -- In two separate procedures, MedStar Health cardiac experts at MedStar Union Memorial Hospital reached new heights in cardiovascular care when…

Read More